Smith Salley Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$410K Sell
3,392
-25
-0.7% -$3.03K 0.02% 188
2025
Q1
$381K Buy
3,417
+25
+0.7% +$2.79K 0.03% 189
2024
Q4
$330K Sell
3,392
-44
-1% -$4.28K 0.02% 203
2024
Q3
$395K Hold
3,436
0.03% 191
2024
Q2
$366K Buy
3,436
+105
+3% +$11.2K 0.03% 185
2024
Q1
$322K Buy
3,331
+98
+3% +$9.48K 0.03% 193
2023
Q4
$326K Sell
3,233
-3
-0.1% -$303 0.02% 205
2023
Q3
$330K Sell
3,236
-3
-0.1% -$306 0.02% 192
2023
Q2
$327K Buy
3,239
+328
+11% +$33.1K 0.02% 190
2023
Q1
$268K Sell
2,911
-36
-1% -$3.31K 0.02% 203
2022
Q4
$267K Sell
2,947
-29,861
-91% -$2.71M 0.02% 196
2022
Q3
$2.49M Buy
32,808
+170
+0.5% +$12.9K 0.23% 86
2022
Q2
$2.76M Sell
32,638
-7,131
-18% -$603K 0.24% 87
2022
Q1
$3.49M Buy
39,769
+934
+2% +$82K 0.26% 80
2021
Q4
$3.4M Sell
38,835
-1,046
-3% -$91.5K 0.24% 84
2021
Q3
$3.26M Buy
39,881
+1,693
+4% +$138K 0.26% 79
2021
Q2
$3.48M Buy
38,188
+572
+2% +$52.2K 0.28% 76
2021
Q1
$3.22M Buy
37,616
+831
+2% +$71K 0.29% 76
2020
Q4
$3.47M Sell
36,785
-261
-0.7% -$24.6K 0.35% 66
2020
Q3
$3.22M Buy
37,046
+235
+0.6% +$20.4K 0.39% 64
2020
Q2
$3.22M Buy
36,811
+1,938
+6% +$169K 0.43% 64
2020
Q1
$2.88M Sell
34,873
-1,247
-3% -$103K 0.48% 59
2019
Q4
$3.42M Buy
36,120
+183
+0.5% +$17.3K 0.45% 64
2019
Q3
$3.12M Buy
35,937
+2,055
+6% +$179K 0.44% 66
2019
Q2
$3.09M Sell
33,882
-5,901
-15% -$539K 0.47% 65
2019
Q1
$3.43M Buy
39,783
+928
+2% +$79.9K 0.55% 60
2018
Q4
$2.99M Sell
38,855
-1,146
-3% -$88.1K 0.55% 61
2018
Q3
$3.09M Sell
40,001
-2,288
-5% -$177K 0.49% 65
2018
Q2
$2.86M Buy
42,289
+756
+2% +$51.2K 0.49% 65
2018
Q1
$3.01M Buy
41,533
+549
+1% +$39.8K 0.54% 66
2017
Q4
$3.08M Buy
40,984
+841
+2% +$63.3K 0.55% 66
2017
Q3
$3.09M Sell
40,143
-133
-0.3% -$10.2K 0.59% 64
2017
Q2
$3.01M Buy
40,276
+1,190
+3% +$89K 0.61% 65
2017
Q1
$2.6M Buy
39,086
+1,730
+5% +$115K 0.53% 69
2016
Q4
$2.44M Buy
37,356
+1,717
+5% +$112K 0.51% 68
2016
Q3
$2.52M Buy
35,639
+5,266
+17% +$373K 0.56% 67
2016
Q2
$2.25M Buy
30,373
+5,477
+22% +$405K 0.52% 65
2016
Q1
$1.62M Buy
24,896
+804
+3% +$52.2K 0.41% 74
2015
Q4
$1.86M Buy
24,092
+1,511
+7% +$116K 0.46% 68
2015
Q3
$1.86M Buy
22,581
+710
+3% +$58.5K 0.5% 65
2015
Q2
$1.93M Buy
21,871
+3,235
+17% +$285K 0.49% 64
2015
Q1
$1.65M Buy
18,636
+3,501
+23% +$309K 0.42% 74
2014
Q4
$1.26M Buy
15,135
+1,682
+13% +$140K 0.33% 86
2014
Q3
$1.14M Buy
13,453
+2,584
+24% +$218K 0.3% 98
2014
Q2
$881K Buy
10,869
+4,192
+63% +$340K 0.24% 109
2014
Q1
$509K Buy
6,677
+1,984
+42% +$151K 0.32% 68
2013
Q4
$338K Buy
+4,693
New +$338K 0.22% 74